BLUE
bluebird bio, Inc.
4.97
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | -40.41% | |
| 1y | -72.25% |
4.97
day range
4.97
52 week range
| Open | 4.74 | Prev Close | 4.97 | Low | 4.97 | High | 4.97 | Mkt Cap | N/A |
| Vol | 1.25M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -11.98 |
| Beta | 0.80 | Short Ratio | 9.53 | Inst. Own | 43.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 37.71 |
| Income Statement | |||
| Total Revenue | 38.71M | ||
| Revenues (USD) | 38.71M | ||
| Cost of Revenue | 12.24M | ||
| Gross Profit | 26.48M | ||
| Operating Expenses | 51.08M | ||
| Research and Development Expense | 17.72M | ||
| Selling, General and Administrative Expense | 30.26M | ||
| Operating Income | -24.61M | ||
| Interest Expense | 5.74M | ||
| Income Tax Expense | 100.00K | ||
| Net Income | -29.07M | ||
| Net Income Common Stock | -29.07M | ||
| Net Income Common Stock (USD) | -29.07M | ||
| Consolidated Income | -29.07M | ||
| Earnings per Basic Share | -2.98 | ||
| Earnings per Basic Share (USD) | -2.98 | ||
| Earnings per Diluted Share | -2.98 | ||
| Earning Before Interest & Taxes (EBIT) | -23.23M | ||
| Earning Before Interest & Taxes (USD) | -23.23M | ||
| Weighted Average Shares | 9.75M | ||
| Weighted Average Shares Diluted | 9.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 78.74M | ||
| Cash and Equivalents (USD) | 78.74M | ||
| Trade and Non-Trade Receivables | 4.06M | ||
| Current Assets | 174.52M | ||
| Property, Plant & Equipment Net | 87.48M | ||
| Total Assets | 295.96M | ||
| Debt Current | 149.28M | ||
| Total Debt | 187.93M | ||
| Current Liabilities | 315.08M | ||
| Debt Non-Current | 38.65M | ||
| Total Liabilities | 353.82M | ||
| Accumulated Retained Earnings (Deficit) | -4.53B | ||
| Accumulated Other Comprehensive Income | -1.88M | ||
| Shareholders Equity | -57.87M | ||
| Shareholders Equity (USD) | -57.87M | ||
| Assets Non-Current | 121.43M | ||
| Total Debt (USD) | 187.93M | ||
| Goodwill and Intangible Assets | 14.96M | ||
| Inventory | 83.28M | ||
| Liabilities Non-Current | 38.74M | ||
| Trade and Non-Trade Payables | 71.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 20.19M | ||
| Net Cash Flow from Financing | 26.71M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.63M | ||
| Capital Expenditure | -859.00K | ||
| Issuance (Repayment) of Debt Securities | -28.02M | ||
| Net Cash Flow from Investing | 3.10M | ||
| Net Cash Flow from Operations | -43.44M | ||
| Share Based Compensation | 1.66M | ||